INBX
Vanguard Group’s Inhibrx, Inc. Common Stock INBX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,861,469
| Closed | -$65.1M | – | 4524 |
|
|
2024
Q1 | $65.1M | Sell |
1,861,469
-12,854
| -0.7% | -$449K | ﹤0.01% | 2058 |
|
|
2023
Q4 | $71.2M | Buy |
1,874,323
+84,512
| +5% | +$3.21M | ﹤0.01% | 2028 |
|
|
2023
Q3 | $32.8M | Buy |
1,789,811
+18,271
| +1% | +$335K | ﹤0.01% | 2334 |
|
|
2023
Q2 | $46M | Sell |
1,771,540
-3,741
| -0.2% | -$97.1K | ﹤0.01% | 2220 |
|
|
2023
Q1 | $33.5M | Buy |
1,775,281
+14,908
| +0.8% | +$281K | ﹤0.01% | 2361 |
|
|
2022
Q4 | $43.4M | Buy |
1,760,373
+292,455
| +20% | +$7.21M | ﹤0.01% | 2250 |
|
|
2022
Q3 | $26.3M | Buy |
1,467,918
+111,802
| +8% | +$2.01M | ﹤0.01% | 2511 |
|
|
2022
Q2 | $15.4M | Buy |
1,356,116
+138,003
| +11% | +$1.57M | ﹤0.01% | 2774 |
|
|
2022
Q1 | $27.1M | Buy |
1,218,113
+11,365
| +0.9% | +$253K | ﹤0.01% | 2610 |
|
|
2021
Q4 | $52.7M | Buy |
1,206,748
+527,223
| +78% | +$23M | ﹤0.01% | 2316 |
|
|
2021
Q3 | $22.6M | Buy |
679,525
+184,676
| +37% | +$6.15M | ﹤0.01% | 2799 |
|
|
2021
Q2 | $13.6M | Buy |
494,849
+107,957
| +28% | +$2.97M | ﹤0.01% | 3050 |
|
|
2021
Q1 | $7.76M | Buy |
386,892
+6,043
| +2% | +$121K | ﹤0.01% | 3297 |
|
|
2020
Q4 | $12.6M | Buy |
380,849
+350,849
| +1,169% | +$11.6M | ﹤0.01% | 2874 |
|
|
2020
Q3 | $540K | Buy |
+30,000
| New | +$540K | ﹤0.01% | 3800 |
|